Add to ORKGwith advanced ovarian cancer. Gynecol Oncol 19H9;34:339-344. 17. De JägerR, Abdel-Nabi H, Serafini A, et al. Current status of cancer immunodetcction with radiolabeled human monoclonal antibodies. Semin NucÃ-Med 1993:23:165-179. 18. Griffin TW, Collins J. Bokhari F. et al. Intraperitoneal immunoeonjugates. Cancer Res 1990;50< suppl):1031s-1038s
The application of intraperitoneal (i.p.) radioimmunotherapy to treat i.p. tumor loci has been limit...
The purpose of this work was to (a) investigate the efficacy of radioimmunotherapy using 211At-MX35 ...
Background: The aim of this study was to investigate the therapeutic efficacy of advanced ovarian ca...
The application of intraperitoneal (i.p.) radioimmunotherapy to treat i.p. tumor loci has been limit...
The a-emitter 211At labeled to a monoclonal antibody has proven safe and effective in treating micro...
Despite debulking surgery and multidrug chemotherapy, advanced stage ovarian cancer has a high morta...
We investigated the safety and pharmacokinetics of 131l-labeled chimeric monoclonal antibody MOv18 (...
Six patients with metastatic breast cancer and malignant pleural effusions and 13 patients with know...
antibody (MAb), were assessed in patients in advanced gastrointes tinal cancer. In addition, the dos...
Radioimmunotherapy (RIT) with i.v. administered radiolabeled IgG can selectively irradiate tumor cel...
Hypothesis: We assessed in in vitro and in vivo models of ovarian cancer the therapeutic efficacy of...
We used radiolabelled monoclonal antibodies (MoAbs) to prove disease persistence after treatment for...
Although 90Y is one of the best radionuclides for radioimmunotherapeutic applications, the lack of g...
maging of primary and metastatic tumors following i.v. administration of radiolabeled antibodies aga...
Here, we assessed in preclinical models the possibility to use radiolabeled 16F12, a mouse monoclona...
The application of intraperitoneal (i.p.) radioimmunotherapy to treat i.p. tumor loci has been limit...
The purpose of this work was to (a) investigate the efficacy of radioimmunotherapy using 211At-MX35 ...
Background: The aim of this study was to investigate the therapeutic efficacy of advanced ovarian ca...
The application of intraperitoneal (i.p.) radioimmunotherapy to treat i.p. tumor loci has been limit...
The a-emitter 211At labeled to a monoclonal antibody has proven safe and effective in treating micro...
Despite debulking surgery and multidrug chemotherapy, advanced stage ovarian cancer has a high morta...
We investigated the safety and pharmacokinetics of 131l-labeled chimeric monoclonal antibody MOv18 (...
Six patients with metastatic breast cancer and malignant pleural effusions and 13 patients with know...
antibody (MAb), were assessed in patients in advanced gastrointes tinal cancer. In addition, the dos...
Radioimmunotherapy (RIT) with i.v. administered radiolabeled IgG can selectively irradiate tumor cel...
Hypothesis: We assessed in in vitro and in vivo models of ovarian cancer the therapeutic efficacy of...
We used radiolabelled monoclonal antibodies (MoAbs) to prove disease persistence after treatment for...
Although 90Y is one of the best radionuclides for radioimmunotherapeutic applications, the lack of g...
maging of primary and metastatic tumors following i.v. administration of radiolabeled antibodies aga...
Here, we assessed in preclinical models the possibility to use radiolabeled 16F12, a mouse monoclona...
The application of intraperitoneal (i.p.) radioimmunotherapy to treat i.p. tumor loci has been limit...
The purpose of this work was to (a) investigate the efficacy of radioimmunotherapy using 211At-MX35 ...
Background: The aim of this study was to investigate the therapeutic efficacy of advanced ovarian ca...